Bioactive Compounds
-
BA2126 MMV009085Summary: MMV009085 is a potent Plasmodium falciparum hexose transporter-specific inhibitor and a potential anti-malarial compound. -
BA2125 MMV008138Summary: MMV008138 is a selective 2-C-methyl-d-erythritol 4-phosphate cytidylyltransferase-targeted antimalarial drug. -
N2660 Alantolactone -
BA2124 DSM502Summary: DSM502 is a pyrrole-based inhibitor of dihydroorotic acid dehydrogenase. -
N2646 Sesamolin -
BA2121 CarbosulfanSummary: Potent inhibitor of CYP3A4, moderate inhibitor of CYP1A1/2 and CYP2C19. -
N2617 Ginsenoside RcSummary: Anticancer, antidiabetic and neuroprotective agent -
BA2119 α-LapachoneSummary: Has trypanocidal activity. -
BA2118 ICASummary: ICA (N-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine) is an SK channel inhibitor. -
BA2117 DNDI-6174Summary: DNDI-6174 is a cytochrome bc1 complex inhibitor with potent in vitro activity against a wide range of Leishmania protozoa.
